Drug firm Ranbaxy Laboratories reported a consolidated net loss of Rs 580.14 crore for the second quarter ended June 30, 2012.
The company had posted a net profit of Rs 245.53 crore during the same period of previous year, Ranbaxy Laboratories said in a filing to the BSE.
The net sales of the company rose to Rs 3,174.06 crore during the quarter under review compared to Rs 2,053.74 crore in the year-ago period.
Shares of Ranbaxy were trading at Rs 500.10 on the BSE in the late afternoon trade, down 2.96 per cent from its previous close.
Published Date: Aug 09, 2012 03:51 pm | Updated Date: Dec 20, 2014 11:06 am